Prevalence of hereditary epidermolysis bullosa in the Russian Federation

Cover Page

Abstract


Goal. To study the prevalence of hereditary epidermolysis bullosa (HEB) in the Russian Federation. Materials and methods. The data on the number of HEB patients by subjects of the Russian Federation as well as their age and disease type were obtained based on questionnaires. The questionnaires were sent to dermatovenerology healthcare institutions from 85 subjects of the Russian Federation. The HEB prevalence rates in the subjects of the Russian Federation were calculated as the ratio of the number of HEB patients in the subject of the Russian Federation to the population size in the subject per million residents. Results. Information about 438 HEB patients (210 female and 228 male) aged 0-66 was collected in 70 subjects of the Russian Federation as of January 1, 2015. The disease type was specified for 139 patients (86 patients with common HEB, 50 patients with dystrophic HEB and 3 patients with the borderline form of HEB). No details about the disease type were provided for 299 patients (68.26%). The HEB prevalence rate in the subjects of the Russian Federation varies from 0 to 19.73 cases per million residents. Conclusion. These data on the HEB prevalence rate in 70 subjects of the Russian Federation are comparable to the data specified in literature sources providing information on the HEB prevalence rate in some foreign states. The data represent the first step to the development of clinical recommendations concerning HEB management and establishment of a register of in the Russian Federation.

A. A. Kubanov

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: noemail@neicon.ru

Russian Federation

V. I. Albanova

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru

Russian Federation

A. E. Karamova

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru

Russian Federation

V. V. Chikin

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru

Russian Federation

L. YE. Melekhina

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru

Russian Federation

YE. V. Bogdanova

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Email: bogdanova@cnikvi.ru

Russian Federation

  1. Fine J.D., Bruckner-Tuderman L., Eady R.A. et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol 2014; 70 (6): 1103-1126.
  2. Fine J.D., Eady R.A., Bauer E.A. et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008; 58 (6): 931-950.
  3. Intong L.R., Murrell D.F. Inherited epidermolysis bullosa: new diagnostic criteria and classification. Clin Dermatol 2012; 30 (1): 70-77.
  4. Fine J.D. Epidemiology of inherited epidermolysis bullosa. In: Fine J.D., Hintner H., editors. Life with epidermolysis bullosa: etiology, diagnosis, multidisciplinary care and therapy. 1st ed. Wien: Springer-Verlag; 2009; 24-29.
  5. Tadini G., Gualandri L., Colombi M. et al. The Italian registry of hereditary epidermolysis bullosa. G Ital Dermatol Venereol 2005; 140 (4): 359-372.
  6. Pohla-Gubo G., Hintner H. Epidermolysis bullosa care in Austria and the Epidermolysis Bullosa House Austria. Dermatol Clin 2010; 28: 415-420.
  7. Kho Y.C., Rhodes L.M., Robertson S.J. et al. Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa. Arch Dermatol 2010; 146: 635-640.
  8. Bruckner-Tuderman L. Epidermolysis bullosa care in Germany. Dermatol Clin 2010; 28: 405-406.
  9. Horn H.M., Priestley G.C., Eady R.A., Tidman M.J. The prevalence of epidermolysis bullosa in Scotland. Br J Dermatol 1997;136 (4): 560-564.
  10. Mellerio J.E. Epidermolysis bullosa care in the United Kingdom. Dermatol Clin 2010; 28: 395-396.
  11. Bodemer C. Epidermolysis bullosa in France: management in the national reference center for genodermatosis. Dermatol Clin 2010; 28: 401-403.
  12. Duipmans J.C., Jonkman M.F. Interdisciplinary management of epidermolysis bullosa in the public setting: The Netherlands as a model of care. Dermatol Clin 2010; 28: 383-386.
  13. Medvecz M., Kârpâti S. Epidermolysis bullosa care in Hungary. Dermatol Clin 2010; 28: 421-423.
  14. Watson R. Care of epidermolysis bullosa in Ireland. Dermatol Clin 2010; 28: 397-399.
  15. Arbuckle H.A. Epidermolysis bullosa care in the United States. Dermatol Clin 2010; 28: 387-389.
  16. Liy-Wong C., Cepeda-Valdes R., SalasAlanis J.C. Epidermolysis bullosa care in Mexico. Dermatol Clin 2010; 28: 393-394.
  17. Castiglia D., Zambruno G. Epidermolysis bullosa care in Italy. Dermatol Clin 2010; 28: 407-409.
  18. Vahlquist A., Tasanen K. Epidermolysis bullosa care in Scandinavia. Dermatol Clin 2010; 28: 425-427.
  19. Danescu S., Has C., Senila S. et al. Epidemiology of inherited epidermolysis bullosa in Romania and genotype-phenotype correlations in patients with dystrophic epidermolysis bullosa. J Eur Acad Dermatol Venereol 2015; 29 (5): 899-903.
  20. Pavicić Z., Kmet-Vizintin P., Kansky A., Dobric' I. Occurrence of hereditary bullous epidermolyses in Croatia. Pediatr Dermatol 1990; 7 (2): 108-110.
  21. Abahussein A.A., Al-Zayir A.A. Epidermolysis bullosa in the eastern province of Saudi Arabia. Int J Dermatiol 1993; 32: 579-581.
  22. McKenna K.E., Walsh M.Y., Bingham E.A. Epidermolysis bullosa in Northern Ireland. Br J Dermatol 1992; 127 (4): 318-321.
  23. Fine J.D., Johnson L.B., Weiner M., Suchindran C. Tracheolaryngeal complications of inherited epidermolysis bullosa: cumulative experience of the National Epidermolysis Bullosa Registry. Laryngoscope 2007; 117 (9): 1652-1660.
  24. Fine J.D., Johnson L.B., Weiner M., Suchindran C.M. Cause-specific risks of childhood death in inherited epidermolysis bullosa. J Pediatr 2008; 152 (2): 276-280.
  25. Fine J.D., Johnson L.B., Weiner M., Suchindran C. Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the National Epidermolysis Bullosa Registry. J Pediatr Gastroenterol Nutr 2008; 46 (2): 147-158.
  26. Fine J.D. Premature death in epidermolysis bullosa. In: Fine JD, Hintner H, editors. Life with epidermolysis bullosa: etiology, diagnosis, multidisciplinary care and therapy. 1st ed. Wien: Springer-Verlag; 2009. 197-203.
  27. Hernandez-Martin A., Aranegui B., Escamez M.J. et al. Prevalence of dystrophic epidermolysis bullosa in Spain: a population-based study using the 3-source capture-recapture method. Evidence of a need for improvement in care. Actas Dermosifiliogr 2013; 104 (10): 890-896.
  28. Kelly-Mancuso G., Kopelan B., Azizkhan R.G., Lucky A.W. Junctional Epidermolysis Bullosa Incidence and Survival: 5-Year Experience of the Dystrophic Epidermolysis Bullosa Research Association of America (DebRA) Nurse Educator, 2007 to 2011. Pediatr Dermatol 2013; 31 (2): 159-162.
  29. Pope E., Lara-Corrales I., Mellerio J. et al. A consensus approach to wound care in epidermolysis bullosa. J Am Acad Dermatol 2012; 67 (5): 904-917.
  30. Новиков П.В. Правовые аспекты редких (орфанных) заболеваний в России и в мире. Медицина 2013; 4; 50-70.
  31. Федеральный закон от 21.11.2011 г. № 323-ФЗ (ред. от 25.06.2012 г.) «Об основах охраны здоровья граждан в Российской Федерации».
  32. Постановление Правительства Российской Федерации от 26 апреля 2012 года № 403 «О порядке ведения Федерального регистра лиц, страдающих жизнеугрожающими и хроническими прогрессирующими редкими (орфанными) заболеваниями, приводящими к сокращению продолжительности жизни граждан или их инвалидности, и его регионального сегмента».
  33. Лебедев А. Бремя орфанных болезней. В современной медицине не должно быть пациентов «сирот». Медицинская газета. № 16 07.03.2012. С. 10. Доступно: http://www. mgzt.ru/%E2%84%96-16-%D0%BE%D1%82-7-%D0%BC%D0%B0%D1%80%D1%82% D0%B0-2012%D0%B3/%D0%B1%D1%80%D 0%B5%D0%BC%D1%8F-%D0%BE%D1%80% D1%84%D0%B0%D0%BD%D0%BD%D1%8B %D1%85-%D0%B1%D0%BE%D0%BB%D0%B 5%D0%B7%D0%BD%D0%B5%D0%B9

Views

Abstract - 73

PDF (Russian) - 16

Refbacks

  • There are currently no refbacks.

Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies